-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$49.5732.33% Upside
AtriCure, Inc. Frequently Asked Questions
-
What analysts cover AtriCure, Inc.?
AtriCure, Inc. has been rated by research analysts at Stifel Nicolaus, Piper Sandler, BTIG, Needham, Oppenheimer, Canaccord Genuity in the past 90 days.